% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Albert:1028207,
      author       = {Albert, Nathalie L. and Preusser, Matthias and
                      Traub-Weidinger, Tatjana and Tolboom, Nelleke and Law, Ian
                      and Palmer, Joshua D. and Guedj, Eric and Furtner, Julia and
                      Fraioli, Francesco and Huang, Raymond Y. and Johnson, Derek
                      R. and Deroose, Christophe M. and Herrmann, Ken and
                      Vogelbaum, Michael and Chang, Susan and Tonn,
                      Joerg-Christian and Weller, Michael and Wen, Patrick Y. and
                      van den Bent, Martin J. and Verger, Antoine and Ivanidze,
                      Jana and Galldiks, Norbert},
      title        = {{J}oint {EANM}/{EANO}/{RANO}/{SNMMI} practice
                      guideline/procedure standards for diagnostics and therapy
                      (theranostics) of meningiomas using radiolabeled
                      somatostatin receptor ligands: version 1.0},
      journal      = {European journal of nuclear medicine and molecular imaging},
      volume       = {51},
      number       = {12},
      issn         = {1619-7070},
      address      = {Heidelberg [u.a.]},
      publisher    = {Springer-Verl.},
      reportid     = {FZJ-2024-04402},
      pages        = {3662 - 3679},
      year         = {2024},
      abstract     = {AbstractPurposeTo provide practice guideline/procedure
                      standards for diagnostics and therapy (theranostics) of
                      meningiomas using radiolabeled somatostatin receptor (SSTR)
                      ligands.MethodsThis joint practice guideline/procedure
                      standard was collaboratively developed by the European
                      Association of Nuclear Medicine (EANM), the Society of
                      Nuclear Medicine and Molecular Imaging (SNMMI), the European
                      Association of Neurooncology (EANO), and the PET task force
                      of the Response Assessment in Neurooncology Working Group
                      (PET/RANO).ResultsPositron emission tomography (PET) using
                      somatostatin receptor (SSTR) ligands can detect meningioma
                      tissue with high sensitivity and specificity and may provide
                      clinically relevant information beyond that obtained from
                      structural magnetic resonance imaging (MRI) or computed
                      tomography (CT) imaging alone. SSTR-directed PET imaging can
                      be particularly useful for differential diagnosis,
                      delineation of meningioma extent, detection of osseous
                      involvement, and the differentiation between posttherapeutic
                      scar tissue and tumour recurrence. Moreover, SSTR-peptide
                      receptor radionuclide therapy (PRRT) is an emerging
                      investigational treatment approach for
                      meningioma.ConclusionThese practice guidelines will define
                      procedure standards for the application of PET imaging in
                      patients with meningiomas and related SSTR-targeted PRRTs in
                      routine practice and clinical trials and will help to
                      harmonize data acquisition and interpretation across
                      centers, facilitate comparability of studies, and to collect
                      larger databases. The current document provides additional
                      information to the evidence-based recommendations from the
                      PET/RANO Working Group regarding the utilization of PET
                      imaging in meningiomas Galldiks (Neuro Oncol.
                      2017;19(12):1576–87). The information provided should be
                      considered in the context of local conditions and
                      regulations.},
      cin          = {INM-3},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {38898354},
      UT           = {WOS:001250257200001},
      doi          = {10.1007/s00259-024-06783-x},
      url          = {https://juser.fz-juelich.de/record/1028207},
}